Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Debt to Equity (2016 - 2018)

Anaptysbio filings provide 3 years of Debt to Equity readings, the most recent being $0.0 for Q4 2018.

  • For the quarter ending Q4 2018, Debt to Equity fell 94.77% year-over-year to $0.0, compared with a TTM value of $0.0 through Dec 2018, down 94.77%, and an annual FY2018 reading of $0.0, down 94.77% over the prior year.
  • Debt to Equity hit $0.0 in Q4 2018 for Anaptysbio, down from $0.0 in the prior quarter.
  • The five-year high for Debt to Equity was $0.12 in Q1 2017, with the low at -$0.36 in Q4 2016.
  • Median Debt to Equity over the past 3 years was $0.02 (2018), compared with a mean of $0.0.
  • The sharpest move saw Debt to Equity skyrocketed 106.8% in 2017, then tumbled 94.77% in 2018.
  • Year by year, Debt to Equity stood at -$0.36 in 2016, then soared by 106.8% to $0.02 in 2017, then crashed by 94.77% to $0.0 in 2018.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.0, $0.0, and $0.01 for Q4 2018, Q3 2018, and Q2 2018 respectively.